It was found that sorafenib increased the expression of S1R and induced most of S1Rs away from nucleus in HCC cells, which could be suppressed by ferrostatin-1, suggesting the potential regulatory role of S1R in ferroptosis. This evidence concerns the gene TMBIM4 and hepatocellular carcinoma.